PAM
Panagora Asset Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-205,382
| Closed | -$3.73M | – | 1505 |
|
|
2022
Q2 | $3.73M | Buy |
205,382
+49,397
| +32% | +$898K | 0.02% | 460 |
|
|
2022
Q1 | $3.93M | Sell |
155,985
-449
| -0.3% | -$11.3K | 0.02% | 471 |
|
|
2021
Q4 | $4.32M | Buy |
156,434
+9,836
| +7% | +$272K | 0.02% | 438 |
|
|
2021
Q3 | $4.73M | Buy |
146,598
+319
| +0.2% | +$10.3K | 0.03% | 441 |
|
|
2021
Q2 | $4.47M | Buy |
+146,279
| New | +$4.47M | 0.02% | 471 |
|
|
2017
Q3 | – | Sell |
-381
| Closed | -$10K | – | 2437 |
|
|
2017
Q2 | $10K | Buy |
+381
| New | +$10K | ﹤0.01% | 2412 |
|
|
2016
Q3 | – | Sell |
-1,850
| Closed | -$57K | – | 2442 |
|
|
2016
Q2 | $57K | Sell |
1,850
-34,822
| -95% | -$1.07M | ﹤0.01% | 2036 |
|
|
2016
Q1 | $1.37M | Buy |
36,672
+28,279
| +337% | +$1.06M | 0.01% | 985 |
|
|
2015
Q4 | $362K | Buy |
8,393
+6,543
| +354% | +$282K | ﹤0.01% | 1426 |
|
|
2015
Q3 | $69K | Hold |
1,850
| – | – | ﹤0.01% | 1910 |
|
|
2015
Q2 | $63K | Hold |
1,850
| – | – | ﹤0.01% | 2085 |
|
|
2015
Q1 | $65K | Hold |
1,850
| – | – | ﹤0.01% | 2038 |
|
|
2014
Q4 | $63K | Sell |
1,850
-5,889
| -76% | -$201K | ﹤0.01% | 1977 |
|
|
2014
Q3 | $298K | Sell |
7,739
-98,716
| -93% | -$3.8M | ﹤0.01% | 1486 |
|
|
2014
Q2 | $4.14M | Sell |
106,455
-2,967
| -3% | -$115K | 0.02% | 573 |
|
|
2014
Q1 | $3.74M | Hold |
109,422
| – | – | 0.02% | 649 |
|
|
2013
Q4 | $2.3M | Buy |
109,422
+10,466
| +11% | +$220K | 0.01% | 807 |
|
|
2013
Q3 | $2.33M | Buy |
98,956
+4,265
| +5% | +$100K | 0.01% | 765 |
|
|
2013
Q2 | $2.54M | Buy |
+94,691
| New | +$2.54M | 0.01% | 698 |
|